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1.350 LElTERS l-0 THE ELXTOR 
7be authors may mean that a single cardiac tumor may be benign 
and mmssociated with tubetose sclerosis or that tumors may be 
cardiity benign because most tumors regressed spontaneously 
or did not require treatment, but they do not say that. Their conclusion 
is therefore misleading and inappropriate. 
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cardiac tumor wbo may not develop tuberous sciemsis is an equally 
significant event. 
Assessing the Significance of 
Preinfarction Angina 
With regard to the letter by Aban concerning the conclusions of our 
report (1). I do not feel that our conciustons arc misleading or 
inapprotniate; rather, Atlan has simply misinterpreted our intended 
context of the word “benign.” 
This huge, retmspective, multiu‘nter study was intended to provide 
epidemio~c information about the disgnosis and management of 
fetal cardii trmmrs. Given the retrospective nature of the study. II I 
not surprisii Atlan notes that some data were not available rar each 
case. Despite these timitations, which were addressed in the di;cuGxt, 
the proportion of fetal patients with tubemus sclerosis and fetal 
tumors was similar to that reported in other peliatric studii (50%). 
The term “benign” was used twice in our report, once in the 
abstract and once in the discussion. In the abstract the contest of the 
word “beatii” refets to tissue type of tumors of 19 tumors discev- 
ered, 17 were rhabdomycenas, a benign tumor. The other IWO tumors 
were not benign-a tibroma that infiltrated throughout much of the 
heart and an atrial hemangioma. In thin mntext, “benign” is neither 
misbding nor &mate. 
In the d&usGn, ?senign” does indeed, and was intended to, refer 
tooutcome. 1 have no prmblem in stating that fetal cardiac tumors “can 
behave in a benign fash&” Not all rumors required intervention; 
some tumors spontaneo4y involuted; and not all patients with tumors 
had tthmus schosis (as in Abn’s personal experience). In fa& as 
Alian 00% out data suggesl that sin& ttmsors are rarety associated 
with tttberotts sderosis; a tinding ditferent from that reported previ- 
o&y (2). This point is further daritied in the tinat sentence of the 
report, which states “therefore, counseTmg of families where singte 
cardiac~ispresentmaybemoreoptimist.ic.” 
I am all tou concerned that physickms performing fetal echocardi- 
onthebasisofanincompleteknowl- 
the published reports. This goint was 
pt+n& made in an editorial by H&a (3). Our multicenter study 
also higftliib the imptam. of completing our knowiedge base of 
fetal diseas before recommending thempies as signi6cant as fetal 
tionofpKgnanq.Thereisnodo~rutattuberous 
a dewastatmg effed on chiien and their famitii 
~~t~~ofa~~~a~~~~asi~ 
Tbc report by Anrai et al. (I) in a recent tssue of tbe Journal concluded 
that patients with ;xeinfarction angina pectoris have a more favorable 
short- and long-term prognosis after hospital admission for acute 
myocardial infarction. This is in contrast to previous studies eaamining 
the issue, which have found that patients with a history of angina 
actually have a worse short- and long-term pmgncsis after a myocar- 
dial infarction (Z-5). As poinicd out in the report by Anzai et al., the 
majority of previous studies did not control for confounding variables. 
such as prior myocardial infarction, severity of coronary disease, signs 
of heart failure and infarction location. In an attempt to overcome 
these limitations, Anmi et al. (1) limited their study population to 
patients without a history of prior infarction and controlled for 
mrmemus confounding variables The authors concluded that 1) prein- 
farction angina is an independent predictor of decreased in-hospital 
mortality, and 2) in patients with an acute anterior infarction, preinfarc- 
tion angina is asxciated with a lauer incidence of cudii rupture, 
ventriadar aneurysm formation and readmiiion for heart failure. They 
hypothesized that tbe benebcial effect of preinfarction angina occurred 
from infarct she limitation passibb secondary to ischcmic preconditioning 
(1). 
Although the patients with and those without a history of angina 
appeared to be we1 matched with respect to age, gender and cardiac 
risk factors, an alternative exptanation for the beneficial effects of 
-gina observed in this study is that preinfarction angisa is a marker 
for a confounding factor that w&s not measured. such as aspirin use. 
The investigators controlled for numerous mediitions, including the 
use of thrombotybk therapy, beta-adrenergic blocking agents, calcium 
antagonists and angiotensin-converting enzyme inhibitors but surpris- 
ingly failed to control for aspirin use. It is quite plausibte that patients 
who developed angina before their first myocardial iofarciion were 
more likely to be taking aspirin. 
In a recent study, Garcia-Dorado et al. (6) prospectively evaluated 
the et&t of previous aspirin use in patients prese .ing with acute 
ischemic syndromes. Tbey found that previous aspirin use was asaoci- 
atedwithashattwvardalesssevereclinical~aodthatinthe 
subset of patients wbo devetoped a myocardial infarction, prior aspirin 
tse was amcxiated with a 38% reduction in peak ueatine kinase (CX). 
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This finding was very similar to the 34% reduction in peak CK seen in 
patients with preinfarction angina in the study of Anzai er al. 
In conclusion, published reports remain conflicting as to whether 
prcinfarction angina is associated with improved clinical outcome. The 
protective effect suggested by thz study of Anzai et al. may be real. or 
it may simply refkxt a higher use of aspirin. Further multivariatc 
analysis is needed to clarity this isue. 
Refemmes 
Barron and Viskin suggested that the beneticial effect of przinfarclion 
angina in our study (I) might be caused by the higher in.zideoce of 
aspirin use in patients with that. without preinfar&tion angina, refe;ring 
to the recent findmgs that previous aspirin use was associated with a 
shifttowardalesssevereclinical~ltawnewiththanwithoutaspirinu~ 
in patients with acute coronary syndrome (2). We agree with the 
amccpt itself that prior use of aspirin diminishes the wverity of acute 
ischemic syndrome. 
However, :hcrc was actually no difference in aspirin use bcfore 
infarction between patients with and without preinfarction angma in 
our study (5 [3W] of 148 vs. 5 IS%] of %), Our studj population are 
quite different from those reported by Garcia-Dorado et al. (2). We 
limited the study population to patients with first 0 wave mFardial 
infarction in contrast to the stu& of Garcia-Dorado et al. (2). which 
included a broad spectrum of patients with non-Q wave myocardial 
infar&m as well as &stable angina. Two explanations arc pcrsible for 
the fact that the iocidencz of prior use of antipiatelet agents was 
unexpectedly low in our studyz i) A large portion of the study 
population had a history of angina < 1 month before infarction. More 
precisely, 55’76 of the patients with preinfardion angina had primary 
unstable angina tha! had developed within I Fk of infarct&n (I). In 
such casz+ it seems to be ditlicult to initiate rherapy, including 
antiplatelet agents, before the onset of myncardial infarction. ‘&ii is in 
amtmst to patients with a prior infarction or non-Q wave infarction 
wha havt a bttgstandii histoty of effort aegitm &c&d with anti- 
platelet agents. 2) As Garcia-Dora&? et al pointed out, patients uith 
The optimal management rtratep for inldnt\ Ullh wprd*entrruiar 
tachycardii is a contrcnersial wbjecz in @IL! ti card&@. The 
recent article in the ,wmal b O’SuIl?.~an er al. t 1 I’ p&d a new 
approach using flecainide for the prevention of rccurrcncc of w 
praventricular txhycardia m mfaq. However, in thee ~IXX&XI. the 
authors misrepresented data m a paper from our irtsutution wnczm- 
ing the use of catheter ablation for mcdiity rcfrzt* .supraventti- 
uiar tacwi in infamy. The authors state that “medica@ refrac- 
tory- uchycardii is often cited as a reason to use radiiofrcquency 
catheter ablation in infants and small &i&en and that thcsc children 
with “medically refractory- arrhythmias have often been treated onl) 
with digotin and propran&. After this statement. the) cite :he report 
from our institution (2). A cursor) rL*xw of that repon would hae 
sbn that in ever? infant and mail &dd who underwent catbcter 
ablatton at our institution, cla5s IC 0T Ill antia+thmic agenl therapy, 
alone or in combination. had failed. Since our +3 of perform4 
surgery for supraventticular arrbyIhmids. we have rescr+ed nonphar- 
macdogic therapy in this age gmup for th@se with failed intensive 
phammco@ii thcmm or a life-threatenir. event (3). We have 
continued to use this pbilosoatry with regard to catheter abiition and 
to date have never performed athcter ablatton in an) infant m whom 
on@ propranolol or dtgoxin therap! had been inekc?zvc. Present&. 
Mta. 
prior use of aspirin resulting in non-Q wave infarction bad hoen 
excluded from ana@is in our smdy. and therefore patemr who 
developd Q wave Infarction ma) be luurciatcd with a k*u incidem of 
aspirin use before mfarction. For thcr rcasom. the benefmal ctfvctr 
of preinfarction angina tinnot be attnhuted to the yor\lMe differcncer 
in the u*e of carthovax-ular medication\ 
indications for Catheter Ablation in Infants 
and Small Children With Reentrant 
Supravenhicular Tachycardia 
